{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:58:13Z","timestamp":1793509093830,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.08.034","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:45:19Z","timestamp":1788968719000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendations for harmonizing definition, recording, and reporting of the annual bleeding rate in hemophilia: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-5020","authenticated-orcid":false,"given":"Alok","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-6166","authenticated-orcid":false,"given":"Stacy E.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-1317","authenticated-orcid":false,"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-0240","authenticated-orcid":false,"given":"Miguel A.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0904-4360","authenticated-orcid":false,"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-0802","authenticated-orcid":false,"given":"Susan","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.08.034_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000286","article-title":"Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report","volume":"3","author":"Rodeghiero","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtha.2026.08.034_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/cts.12794","article-title":"Annual bleeding rates: pitfalls of clinical trial outcomes in hemophilia patients","volume":"13","author":"Keipert","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtha.2026.08.034_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2026.08.035","article-title":"Assessment of documentation & reporting methods for annual bleeding rate in hemophilia clinical trials: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders","author":"Croteau","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.034_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/hae.12750","article-title":"A systematic review of definitions and reporting of bleeding outcome measures in haemophilia","volume":"21","author":"Chai-Adisaksopha","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.034_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/hae.12667","article-title":"Differentiating between signs of intra-articular joint bleeding and chronic arthropathy in haemophilia: a narrative review of the literature","volume":"21","author":"Timmer","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.034_bib6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.034_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.08.034_bib8","volume":". 53","author":"Cameron","year":"2013"},{"key":"10.1016\/j.jtha.2026.08.034_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00952990.2011.597280","article-title":"Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial","volume":"37","author":"Hu","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jtha.2026.08.034_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12782","article-title":"Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3","volume":"6","author":"Callaghan","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.034_bib15","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S2352-3026(23)00037-6","article-title":"Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A\/B): a multicentre, open-label, randomised, phase 3 trial","volume":"10","author":"Srivastava","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2026.08.034_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2216455","article-title":"Phase 3 trial of concizumab in hemophilia with inhibitors","volume":"389","author":"Matsushita","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.08.034_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2517384","article-title":"Mim8 bispecific antibody prophylaxis in hemophilia A with or without inhibitors","volume":"394","author":"Mancuso","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.08.034_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2012-12-470898","article-title":"Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s","volume":"122","author":"Fischer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.08.034_bib12","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1111\/hae.14624","article-title":"Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia","volume":"28","author":"Matlary","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.034_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/hae.14303","article-title":"Ultrasound and magnetic resonance imaging for the detection of blood: an ex-vivo study","volume":"27","author":"Regi","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.034_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00774-024-01520-8","article-title":"Inflammatory diseases causing joint and bone destruction: rheumatoid arthritis and hemophilic arthropathy","volume":"42","author":"Terashima","year":"2024","journal-title":"J Bone Miner Metab"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:47:45Z","timestamp":1792813665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626005593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"alternative-id":["S1538783626005593"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.08.034","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for harmonizing definition, recording, and reporting of the annual bleeding rate in hemophilia: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}